In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort Study

Lung. 2019 Dec;197(6):699-707. doi: 10.1007/s00408-019-00270-z. Epub 2019 Sep 20.

Abstract

Purpose: In patients with idiopathic pulmonary fibrosis (IPF), hospitalizations are associated with high mortality. We sought to determine in-hospital mortality rates and factors associated with in-hospital mortality in patients with IPF.

Methods: Patients with IPF were identified from the Premier Healthcare Database, a representative administrative dataset that includes > 20% of hospital discharges in the US, using an algorithm based on diagnostic codes and billing data. We used logistic regression to analyze associations between patient-, hospital-, and treatment-related characteristics and a composite primary outcome of death during the index visit, lung transplant during the index visit and > 1 day after admission, or death during a readmission within 90 days.

Results: The cohort comprised 6665 patients with IPF hospitalized between October 2011 and October 2014. A total of 963 (14.4%) met the primary outcome. Factors significantly associated with a higher risk of the primary outcome included mechanical ventilation [odds ratio 4.65 (95% CI 3.73, 5.80)], admission to the intensive care unit [1.83 (1.52, 2.21)], treatment with opioids (3.06 [2.57, 3.65]), and a diagnosis of pneumonia [1.44 (1.21, 1.71)]. Factors significantly associated with a lower risk included concurrent chronic obstructive pulmonary disease [0.65 (0.55, 0.77)] and female sex [0.67 (0.57, 0.79)].

Conclusions: Patients with IPF, particularly those receiving mechanical ventilation or intensive care, are at substantial risk of death or lung transplant during hospitalization or death during a readmission within 90 days.

Keywords: Critical care; Hospitalization; Intensive care; Interstitial lung disease; Mechanical ventilation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Analgesics, Opioid / therapeutic use
  • Cohort Studies
  • Comorbidity
  • Female
  • Hospital Mortality*
  • Humans
  • Idiopathic Pulmonary Fibrosis / epidemiology
  • Idiopathic Pulmonary Fibrosis / mortality*
  • Idiopathic Pulmonary Fibrosis / therapy
  • Intensive Care Units
  • Logistic Models
  • Lung Transplantation / statistics & numerical data*
  • Male
  • Middle Aged
  • Patient Readmission / statistics & numerical data
  • Pneumonia / epidemiology
  • Protective Factors
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Respiration, Artificial
  • Risk Factors
  • Sex Factors
  • United States / epidemiology

Substances

  • Analgesics, Opioid